You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

teriflunomide

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HAM/TSP Trial run by the NINDS (Teriflunomide)

Recruiting
  • HAM/TSP
  • Teriflunomide
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Mechanistic Studies of Teriflunomide in RRMS

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Teriflunomide
  • Ann Arbor, Michigan
    University of Michigan
Jul 27, 2022

Multiple Sclerosis Trial (Frexalimab, Teriflunomide, Placebo infusion)

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Nov 15, 2023

Multiple Sclerosis Trial in Moscow (BCD-132, Teriflunomide)

Recruiting
  • Multiple Sclerosis
  • BCD-132
  • Teriflunomide
  • Moscow, Russian Federation
    State Budgetary Healthcare Institution of the Moscow Region M.F.
May 18, 2022

Teriflunomide Observational Effectiveness Study

Completed
  • Relapsing Remitting Multiple Sclerosis
  • Teriflunomide
  • Montréal, Quebec, Canada
    CHUM
Aug 17, 2021

Relationship Between Oral DMT Burden and Adherence in MS

Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Melbourne, Victoria, Australia
    Monash University
Aug 28, 2022

Multiple Sclerosis Trial in Nizhny Novgorod (BCD-132, 125 mg, Teriflunomide, Placebo)

Active, not recruiting
  • Multiple Sclerosis
  • BCD-132, 125 mg
  • +3 more
  • Nizhny Novgorod, Russian Federation
    State Budgetary Healthcare Institution of Nizhny Novgorod region
Sep 6, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (Remibrutinib, Teriflunomide)

Recruiting
  • Relapsing Multiple Sclerosis
  • Fullerton, California
  • +38 more
Aug 12, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Remibrutinib, Teriflunomide)

Recruiting
  • Relapsing Multiple Sclerosis
  • Hanford, California
  • +41 more
Aug 5, 2022

Disease Activity in Patients Treated With Teriflunomide

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Teriflunomide
  • Montréal, Quebec, Canada
    Department of Pathology
Mar 23, 2021

Teriflunomide Tecfidera LMCE

Completed
  • Tecfidera
  • Teriflunomide
  • Dimethyl Fumarate
  • Teriflunomide
  • Buffalo, New York
    Buffalo Neuroimaging Analysis Center
Jan 4, 2021

Relapsing Multiple Sclerosis (RMS) Trial in United States (Ublituximab, Teriflunomide, Oral Placebo)

Completed
Has Results
  • Relapsing Multiple Sclerosis (RMS)
  • Ublituximab
  • +3 more
  • Phoenix, Arizona
  • +12 more
Nov 11, 2021

Teriflunomide Elimination, Healthy Volunteers Trial in Tampa (teriflunomide, Colestipol)

Terminated
Has Results
  • Teriflunomide Elimination
  • Healthy Volunteers
  • Tampa, Florida
    USF Carol and Frank Morsani Center for Advanced Healthcare
Apr 1, 2020

Relapsing Multiple Sclerosis (RMS) Trial in United States (Ublituximab, Teriflunomide, Oral Placebo)

Completed
Has Results
  • Relapsing Multiple Sclerosis (RMS)
  • Ublituximab
  • +3 more
  • Carlsbad, California
  • +13 more
Nov 5, 2021

Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, teriflunomide, )

Recruiting
  • Relapsing Multiple Sclerosis
  • Cullman, Alabama
  • +138 more
Jan 5, 2023

Multiple Sclerosis Trial in Worldwide (ponesimod, teriflunomide)

Completed
Has Results
  • Multiple Sclerosis
  • Carlsbad, California
  • +161 more
Jan 24, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo (match to Teriflunomide), Teriflunomide)

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Cullman, Alabama
  • +275 more
Nov 7, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo (match to Teriflunomide), Teriflunomide)

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Mobile, Alabama
  • +278 more
Nov 7, 2022

Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, teriflunomide, )

Recruiting
  • Relapsing Multiple Sclerosis
  • Homewood, Alabama
  • +156 more
Jan 5, 2023

Multiple Sclerosis Trial in France (Teriflunomide)

Unknown status
  • Multiple Sclerosis
  • Teriflunomide
  • Besançon, France
  • +4 more
Mar 16, 2018

Multiple Sclerosis Trial in Worldwide (Teriflunomide, Placebo)

Completed
Has Results
  • Multiple Sclerosis
  • Teriflunomide
  • Placebo
  • Cullman, Alabama
  • +130 more
Jan 20, 2017

Multiple Sclerosis Trial in Worldwide (Teriflunomide)

Completed
Has Results
  • Multiple Sclerosis
  • Teriflunomide
  • Birmingham, Alabama
  • +168 more
Oct 10, 2016

Multiple Sclerosis Trial in Worldwide (Interferon ß-1a, Teriflunomide)

Completed
Has Results
  • Multiple Sclerosis
  • Interferon β-1a
  • Teriflunomide
  • Bruxelles, Belgium
  • +53 more
May 4, 2016

Multiple Sclerosis Trial in Worldwide (teriflunomide, Interferon-ß-1, Influenza vaccine)

Completed
Has Results
  • Multiple Sclerosis
  • teriflunomide
  • +2 more
  • Wien, Austria
  • +13 more
Jan 21, 2016

Multiple Sclerosis Trial in Worldwide (Placebo, Teriflunomide)

Completed
Has Results
  • Multiple Sclerosis
  • Placebo
  • Teriflunomide
  • Phoenix, Arizona
  • +192 more
May 27, 2016